nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer
|
Masuda, Yuki |
|
2010 |
59 |
10 |
p. 1531-1541 |
artikel |
2 |
Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy?
|
Szala, Stanisław |
|
2010 |
59 |
10 |
p. 1449-1455 |
artikel |
3 |
CD8+ T cell recognition of polymorphic wild-type sequence p5365–73 peptides in squamous cell carcinoma of the head and neck
|
Andrade Filho, Pedro A. |
|
2010 |
59 |
10 |
p. 1561-1568 |
artikel |
4 |
CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection
|
Yamada, Noriyuki |
|
2010 |
59 |
10 |
p. 1543-1549 |
artikel |
5 |
Cetuximab-dependent ADCC in cancer: dream or reality?
|
Ottaiano, Alessandro |
|
2010 |
59 |
10 |
p. 1607-1608 |
artikel |
6 |
DNA vaccination strategies for anti-tumour effective gene therapy protocols
|
Signori, Emanuela |
|
2010 |
59 |
10 |
p. 1583-1591 |
artikel |
7 |
Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion
|
Goff, Stephanie L. |
|
2010 |
59 |
10 |
p. 1551-1560 |
artikel |
8 |
Identification and characterization of Ch806 mimotopes
|
Yang, Lin |
|
2010 |
59 |
10 |
p. 1481-1487 |
artikel |
9 |
Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study
|
Slavin, Shimon |
|
2010 |
59 |
10 |
p. 1511-1519 |
artikel |
10 |
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
|
Ostrand-Rosenberg, Suzanne |
|
2010 |
59 |
10 |
p. 1593-1600 |
artikel |
11 |
Ninth international conference on progress in vaccination against cancer (PIVAC 9), 8–10 October 2009, Sofia, Bulgaria
|
Naumova, Elissaveta |
|
2010 |
59 |
10 |
p. 1569-1572 |
artikel |
12 |
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
|
Bennouna, Jaafar |
|
2010 |
59 |
10 |
p. 1521-1530 |
artikel |
13 |
Pre-operative intracellular glutathione levels of peripheral monocytes as a biomarker to predict survival of colorectal cancer patients
|
Uno, Kazuko |
|
2010 |
59 |
10 |
p. 1457-1465 |
artikel |
14 |
Response definition criteria for ELISPOT assays revisited
|
Moodie, Z. |
|
2010 |
59 |
10 |
p. 1489-1501 |
artikel |
15 |
Response to the letter to the editors by Ottaiano et al.: “Cetuximab-dependent ADCC in cancer: dream or reality?”
|
Ferris, Robert L. |
|
2010 |
59 |
10 |
p. 1609-1610 |
artikel |
16 |
The effect of radiotherapy on NKT cells in patients with advanced head and neck cancer
|
Kobayashi, Kouichi |
|
2010 |
59 |
10 |
p. 1503-1509 |
artikel |
17 |
The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions
|
Garrido, Federico |
|
2010 |
59 |
10 |
p. 1601-1606 |
artikel |
18 |
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
|
Schreibelt, Gerty |
|
2010 |
59 |
10 |
p. 1573-1582 |
artikel |
19 |
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
|
Krug, Lee M. |
|
2010 |
59 |
10 |
p. 1467-1479 |
artikel |